Docking studies on monoamine oxidase-B inhibitors:: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds

被引:59
作者
Toprakçi, M
Yelekçi, K
机构
[1] Kadir Has Univ, Sch Med, Dept Biochem, TR-34230 Cibali Fatih Istanbul, Turkey
[2] Kadir Has Univ, Fac Arts & Sci, TR-34230 Cibali Fatih Istanbul, Turkey
关键词
docking; MAO-B inhibitors;
D O I
10.1016/j.bmcl.2005.07.043
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monoamine oxidase (EC1.4.3.4; MAO) is a mitochondrial outer membrane flavoenzyme that catalyzes the oxidation of biogenic amines. It has two distinct isozymic forms designated MAO-A and MAO-B, each displaying different substrate and inhibitor specificities. They are the well-known targets for antidepressant and neuroprotective drugs. Elucidation of the X-ray crystallographic structure of MAO-B has opened the way for molecular modeling studies. A series of experimentally tested (1-10) model compounds has been docked computationally to the active site of the MAO-B enzyme. The AutoDock 3.0.5 program was employed to perform automated molecular docking. The free energies of binding (Delta G) and inhibition constants (K-i) of the docked compounds were calculated by the Lamarckian Genetic Algorithm (LGA) of AutoDock 3.0.5. Excellent to good correlations between the calculated and experimental K-i values were obtained. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4438 / 4446
页数:9
相关论文
共 32 条
[1]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[2]   GROMACS - A MESSAGE-PASSING PARALLEL MOLECULAR-DYNAMICS IMPLEMENTATION [J].
BERENDSEN, HJC ;
VANDERSPOEL, D ;
VANDRUNEN, R .
COMPUTER PHYSICS COMMUNICATIONS, 1995, 91 (1-3) :43-56
[3]   Recent changes to RasMol, recombining the variants [J].
Bernstein, HJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (09) :453-455
[4]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[5]   Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class [J].
Binda, C ;
Hubálek, F ;
Li, M ;
Herzig, Y ;
Sterling, J ;
Edmondson, DE ;
Mattevi, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1767-1774
[6]   Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures [J].
Binda, C ;
Li, M ;
Hubálek, F ;
Restelli, N ;
Edmondson, DE ;
Mattevi, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) :9750-9755
[7]  
BRUNELLO N, 1995, DEPRESSION, V2, P119
[8]   Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis [J].
Cesura, AM ;
Gottowik, J ;
Lahm, HW ;
Lang, G ;
Imhof, R ;
Malherbe, P ;
Rothlisberger, U ;
DaPrada, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (03) :996-1002
[9]  
CESURA AM, 2000, PROG DRUG RES, V60, P709
[10]   Computer modeling of oxygen containing heptylamines as monoamine oxidase inactivators [J].
Erdem, SS ;
Yelekçi, K .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2001, 572 :97-106